| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 144 517 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 10 000 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 50 136 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 41 250 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 41 250 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 28 508 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 28 508 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 27 993 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27 993 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 55 986 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 55 986 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 32 072 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 55 986 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11 874 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 6 001 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7 363 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 82 500 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 14 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 50 974 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 38 250 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 45 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 37 708 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 34 533 | — | deriv |
| 28 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 55 986 | 0.00 USD | |
| 22 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 7 832 | 21.77 USD | |